Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology right now.

The AI drug boom has a long way to go before reaching patients.

Call AI in biotech hype at your peril. There are real reasons that pharmaceutical companies are embracing this technology right now.